trending Market Intelligence /marketintelligence/en/news-insights/trending/oLUWd0jjoF2NlDEP_EI-Uw2 content esgSubNav
In This List

Novogen to change name, consolidate stocks

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Novogen to change name, consolidate stocks

Novogen Ltd is seeking shareholder approval to change its name to Kazia Therapeutics Ltd. and to consolidate its shares.

Novogen intends to implement a 1-for-10 share consolidation to have a more appropriate capital structure as well as reduce administrative costs resulting from a large number of issued shares.

The share consolidation is expected to be effective Dec. 31.